Latest News

21 September 2020
STELFONTA® USA Marketing Authorisation Progress

Read more

13 August 2020
QBiotics announces clinical collaboration with MSD targeting unresectable melanoma

Read more

22 July 2020
QBiotics doses first Australian patient in Phase I/II clinical trial for head and neck cancer

Read more

27 April 2020
QBiotics commercialises first tigilanol tiglate pharmaceutical product with launch of STELFONTA®

Read more